AmerisourceBergen 2011 Annual Report Download - page 11

and represents the third largest network of retail
stores in the U.S.
Increasingly, community pharmacies are expanding
beyond the role of the traditional retail pharmacy and
hospitals are expanding their reach across the entire
spectrum of care. As a result, the collaborative approach
we have taken over the last year has also extended into
the services we provide to hospitals and health systems.
Our core offerings for our health systems customers
cover three primary areas: quality care solutions,
market growth solutions, and cost control solutions.
Our quality care solutions are designed to help ensure
a health system’s medication policies and processes
support medication tracking and enhance the
coordination of patient care.ABDC’s market growth
solutions expand the reach of a health system beyond
traditional boundaries and into areas such as employee
and employer services, and to coordinating efforts with
community pharmacies. Importantly, our cost control
solutions extend well beyond inventory management
services to include performance assessments of all
areas of institutional pharmacy operations. Our ultimate
goal is to focus our business on supplying our provider
and manufacturer customers with the innovative
products and services they need to succeed in a
marketplace that is expanding beyond traditional
services and into specialty services.
Our commitment to innovation is best
demonstrated by the long-term success and market
leadership of AmerisourceBergen Specialty Group.
Serving both physicians and manufacturers of specialty
and biotech products,ABSG is the U.S.’s largest
oncology products distributor, the largest blood
plasma products distributor, the leading distributor
in dialysis, and maintains strong positions in vaccine
distribution and in other physician specialties such
as ophthalmology and rheumatology. In addition to
distribution and logistics
services,ABSG provides
analytics and business
intelligence services,
including practice
management tools
that measure clinical
performance and streamline
claims management.The
acquisition of IntrinsiQ in
late fiscal 2011 enhanced
our informatics offerings
for both physicians and
manufacturers, by providing
tools to track and manage complex chemotherapy
dosing, and information to support treatment decisions.
As ABSG strives to be the preferred partner to
physicians and manufacturers, we help ensure that
complex biotech and other sophisticated specialty
therapies are distributed efficiently and dispensed
effectively. Using our physician networks, such as
ION Solutions, we assist manufacturers in getting
both new and mature products to the right physicians
and patients as quickly as possible. Our patient access,
medication adherence, and other product support
programs help physicians keep patients on the proper
regimens and help patients manage the cost of care.
Similarly, as more generics become available for
specialty products, and biotech manufacturers consider
the possibilities of bringing biosimilars to market in
the U.S., AmerisourceBergen is uniquely positioned
in the market to drive economic value for physicians,
patients, manufacturers, and payers alike by providing
market-leading distribution networks and product
support services.
As the healthcare marketplace becomes increasingly
more complex, and providers and manufacturers
ABSG is the leader in oncology
distribution, blood plasma
products and dialysis distribution,
and has strong positions in
several other specialty areas.
Our commitment to innovation is
best demonstrated by the long-term
success and market leadership of
AmerisourceBergen Specialty Group.
9
continued
continued from previous page